Protein nitration in Parkinson's disease
- PMID: 9600227
- DOI: 10.1097/00005072-199804000-00006
Protein nitration in Parkinson's disease
Abstract
Oxidative stress has been proposed as a pathogenetic mechanism in Parkinson's disease (PD). One mechanism of oxidative cellular injury is the nitration of protein tyrosine residues, mediated by peroxynitrite, a reaction product of nitric oxide and superoxide radicals. We demonstrate here the presence of nitrotyrosine immunoreactivity in Lewy bodies within melanized neurons and in amorphous deposits associated with intact and degenerating neurons. The core of the Lewy body was frequently intensely immunolabeled, while the rim was lightly labeled or unlabeled. This likely reflects the fact that tyrosine residues of neurofilament proteins are primarily localized to Lewy body cores, and suggests that nitrotyrosine is present in neurofilament protein itself. Although these observations are as yet unable to provide a definitive link between oxidative stress and neuronal dysfunction, they demonstrate that oxidative stress has occurred within the vulnerable neurons of PD, leaving a permanent marker of oxidative modification of neuronal proteins within the target cells of neurodegeneration. In addition, these observations provide a potential link between excitotoxicity and oxidative stress within the vulnerable neurons of PD and represent a pathogenetic mechanism in common with the 2 other major age-related neurodegenerative diseases, Alzheimer disease and amyotrophic lateral sclerosis.
Similar articles
-
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.J Comp Neurol. 1993 Mar 15;329(3):328-36. doi: 10.1002/cne.903290304. J Comp Neurol. 1993. PMID: 8459049
-
TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.Brain Res. 2000 Sep 22;877(2):379-81. doi: 10.1016/s0006-8993(00)02702-5. Brain Res. 2000. PMID: 10986355
-
Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1039-46. doi: 10.1136/jnnp.57.9.1039. J Neurol Neurosurg Psychiatry. 1994. PMID: 7916375 Free PMC article.
-
Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?Aging Cell. 2002 Oct;1(1):17-21. doi: 10.1046/j.1474-9728.2002.00001.x. Aging Cell. 2002. PMID: 12882349 Review.
-
Proteomic approach to studying Parkinson's disease.Mol Neurobiol. 2004 Jun;29(3):271-88. doi: 10.1385/MN:29:3:271. Mol Neurobiol. 2004. PMID: 15181239 Review.
Cited by
-
Prospects for redox-based therapy in neurodegenerative diseases.Neurotox Res. 2000;2(2-3):229-37. doi: 10.1007/BF03033796. Neurotox Res. 2000. PMID: 16787843
-
Neuronal nitric oxide synthase expression in cerebellar mutant mice.Cerebellum. 2004;3(3):141-51. doi: 10.1080/14734220410031927. Cerebellum. 2004. PMID: 15543804 Review.
-
Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.Neurochem Res. 2011 Aug;36(8):1452-63. doi: 10.1007/s11064-011-0471-9. Epub 2011 Apr 12. Neurochem Res. 2011. PMID: 21484266
-
Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.Dialogues Clin Neurosci. 2004 Sep;6(3):259-80. doi: 10.31887/DCNS.2004.6.3/galexander. Dialogues Clin Neurosci. 2004. PMID: 22033559 Free PMC article.
-
Microglial ion channels as potential targets for neuroprotection in Parkinson's disease.Neural Plast. 2013;2013:587418. doi: 10.1155/2013/587418. Epub 2013 Oct 30. Neural Plast. 2013. PMID: 24288626 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical